TOKYO - Kirin Beverage Company will launch nationwide sales of Kirin Oishii Immune Care, a functional food that supports the maintenance of immune function in healthy people, containing Kirin's proprietary material L. lactis strain Plasma [postbiotic] (LC-Plasma), on Tuesday, March 28.
In addition, to further expand an 'immune care' habit, Kirin Beverage will launch a new package design for Kirin iMUSE Immune Care Water and a new taste and package design for Kirin Nama-cha Immune Care on March 21. In addition, a new 280ml PET bottle size of Kirin Nama-cha Immune Care will go on sale on April 4, to expand touchpoints with consumers. Through its LC-Plasma-containing beverages, Kirin Beverage is committed to bringing 'health with good taste for everyone's daily life.'
According to our survey in 2022, while consumers are highly interested in immunity, few are taking 'immune care' actions, and there is a large gap between awareness and action 2. This suggests that there is an opportunity for further growth in the 'immune care' market. We believe that this is due to a lack of awareness of 'immune care' and a lack of product options, so Kirin Beverage has been working to raise awareness of 'immune care' and expand the lineup of products that can be easily taken. Among these, Kirin iMUSE Morning Immune Care, a 100ml drinkable size product launched nationwide in March 2022, has received highly praise for its small volume, easy-to-use container design that conveys a sense of functionality, and easy-to-drink taste, stimulating repeat purchases and demand for bulk purchases such as six-packs. As a result, the annual sales volume of beverages containing LC-Plasma increased by approximately 20% year on year in 2022.
Another survey revealed that consumers place a high priority on taste and health benefits when purchasing drinkable yogurt and lactic acid beverages, indicating that they are looking for both function and taste3. Kirin Oishii Immune care has a name and design that conveys both function and good taste, and is satisfying to drink, yet has a refreshing taste with just the right amount of sweetness and acidity.
Kirin Nama-cha Immune Care will have new taste and packaging to make it an easy-to-use 'immune care tea 4,' and will be available in a new 280 ml volume. Kirin iMUSE Immune Care Water will also have new packaging so that the product's features can be easily recognized at a glance. Against the backdrop of the recent increase in health consciousness, Kirin will continue to support consumers' health through its 'immune care' products.
About Kirin Holdings
Kirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe.
Kirin Holdings can trace its roots to Japan Brewery which was established in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers. In 2007, Kirin Holdings was established as a pure holding company and is currently focusing on boosting its Health Science domain.
Under the Kirin Group Vision 2027 (KV 2027), a long-term management plan launched in 2019, the Kirin Group aims to become 'A global leader in CSV creating value across our world of Food & Beverages to Pharmaceuticals.' Going forward, the Kirin Group will continue to leverage its strengths to create both social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value.
Contact:
Tel: 81-3-6837-7028
KIRIN GROUP HOLDINGS LIMITED 
